Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin added at initiation of insulin therapy in type 2 diabetes
NL-OMON37974Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of vildagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Insulin dose required for glycemic control. Started Nov 2009; status: active, not recruiting.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON37974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37974.